DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Relafen
Drug: Nabumetone
First Posted Date
2010-07-19
Last Posted Date
2010-07-19
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
30
Registration Number
NCT01164826
Locations
🇮🇳

Bioserve Clinical Research Pvt. Ltd., Hyderabad, Andhra Pradesh, India

Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Relafen
Drug: Nabumetone
First Posted Date
2010-07-19
Last Posted Date
2010-07-19
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
44
Registration Number
NCT01164813
Locations
🇮🇳

Bioserve Clinical Research Pvt. Ltd., Hyderabad, Andhra Pradesh, India

Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Trandolapril
Drug: Mavik
First Posted Date
2010-07-19
Last Posted Date
2010-07-19
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
52
Registration Number
NCT01164800
Locations
🇮🇳

Wellquest Clinical Research, Mumbai, Maharashtra, India

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Altace
Drug: Ramipril
First Posted Date
2010-07-19
Last Posted Date
2010-07-19
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01164761
Locations
🇮🇳

Lambda Therapeutic Research Limited, Ahmedabad, Gujrat, India

Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Trandolapril
Drug: Mavik
First Posted Date
2010-07-19
Last Posted Date
2010-07-19
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
52
Registration Number
NCT01164787
Locations
🇮🇳

Wellquest Clinical Research, Mumbai, Maharashtra, India

Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Zonegran
Drug: Zonisamide
First Posted Date
2010-07-14
Last Posted Date
2010-07-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01161966
Locations
🇺🇸

SFBC Ft. Myers, Inc., Fort Myers, Florida, United States

Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Nizatidine
Drug: Axid
First Posted Date
2010-07-14
Last Posted Date
2010-07-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01161927

Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Axid
Drug: Nizatidine
First Posted Date
2010-07-14
Last Posted Date
2010-07-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01161940

Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Zonisamide
Drug: Zonegran
First Posted Date
2010-07-14
Last Posted Date
2010-07-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01161979
Locations
🇺🇸

SFBC Ft. Myers, Inc., Fort Myers, Florida, United States

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Meloxicam
First Posted Date
2010-07-13
Last Posted Date
2010-07-13
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
28
Registration Number
NCT01161134
Locations
🇨🇦

Allied Research International Inc., Mississauga, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy